Biomedicines (Mar 2022)

Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy

  • Giulia Gianferrari,
  • Ilaria Martinelli,
  • Elisabetta Zucchi,
  • Cecilia Simonini,
  • Nicola Fini,
  • Marco Vinceti,
  • Salvatore Ferro,
  • Annalisa Gessani,
  • Elena Canali,
  • Franco Valzania,
  • Elisabetta Sette,
  • Maura Pugliatti,
  • Valeria Tugnoli,
  • Lucia Zinno,
  • Salvatore Stano,
  • Mario Santangelo,
  • Silvia De Pasqua,
  • Emilio Terlizzi,
  • Donata Guidetti,
  • Doriana Medici,
  • Fabrizio Salvi,
  • Rocco Liguori,
  • Veria Vacchiano,
  • Mario Casmiro,
  • Pietro Querzani,
  • Marco Currò Dossi,
  • Alberto Patuelli,
  • Simonetta Morresi,
  • Marco Longoni,
  • Patrizia De Massis,
  • Rita Rinaldi,
  • Annamaria Borghi,
  • ERRALS GROUP,
  • Amedeo Amedei,
  • Jessica Mandrioli

DOI
https://doi.org/10.3390/biomedicines10040819
Journal volume & issue
Vol. 10, no. 4
p. 819

Abstract

Read online

Increased incidence rates of amyotrophic lateral sclerosis (ALS) have been recently reported across various Western countries, although geographic and temporal variations in terms of incidence, clinical features and genetics are not fully elucidated. This study aimed to describe demographic, clinical feature and genotype–phenotype correlations of ALS cases over the last decade in the Emilia Romagna Region (ERR). From 2009 to 2019, our prospective population-based registry of ALS in the ERR of Northern Italy recorded 1613 patients receiving a diagnosis of ALS. The age- and sex-adjusted incidence rate was 3.13/100,000 population (M/F ratio: 1.21). The mean age at onset was 67.01 years; women, bulbar and respiratory phenotypes were associated with an older age, while C9orf72-mutated patients were generally younger. After peaking at 70–75 years, incidence rates, among women only, showed a bimodal distribution with a second slight increase after reaching 90 years of age. Familial cases comprised 12%, of which one quarter could be attributed to an ALS-related mutation. More than 70% of C9orf72-expanded patients had a family history of ALS/fronto-temporal dementia (FTD); 22.58% of patients with FTD at diagnosis had C9orf72 expansion (OR 6.34, p = 0.004). In addition to a high ALS incidence suggesting exhaustiveness of case ascertainment, this study highlights interesting phenotype–genotype correlations in the ALS population of ERR.

Keywords